Should Patients With “Low Disease Activity” Rheumatoid Arthritis Stop Using Tumor Necrosis Factor Inhibitor Drugs?

New evidence provides more information to help physicians and patients make the decision.

Article Excerpt

Tumor necrosis factor inhibitor drugs (TNFi) are biologic agents used worldwide, known to be effective in the treatment of inflammatory conditions such as rheumatoid arthritis (RA), and also such conditions

Comments

Leave a Reply

×
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×
×

Please Log In

You are trying to access subscribers-only content. If you are a subscriber, use the form below to log in.

Subscribers will have unlimited access to the magazine that helps people live more sustainable, self-reliant lives, with feature stories on tending the garden, managing the homestead, raising healthy livestock and more!

This setting should only be used on your home or work computer.

×

Please Log In

You are trying to access subscribers-only content. If you are a subscriber, use the form below to log in.

Subscribers will have unlimited access to the magazine that helps the small-scale poultry enthusiast raise healthy, happy, productive flocks for eggs, meat or fun - from the countryside to the urban homestead!

This setting should only be used on your home or work computer.

Send this to a friend

Hi,
I thought you might be interested in this article on https://universityhealthnews.com: Should Patients With “Low Disease Activity” Rheumatoid Arthritis Stop Using Tumor Necrosis Factor Inhibitor Drugs?

-- Read the story at https://universityhealthnews.com/topics/bones-joints-topics/should-patients-with-low-disease-activity-rheumatoid-arthritis-stop-using-tumor-necrosis-factor-inhibitor-drugs/